Probiotics for pharma: South Korean giant CKD Bio eyeing novel medicines with probiotic formulation
South Korean pharma giant CKD Holdings Corp is researching the different health benefits of probiotics and sees this as a starting point into producing new pharma solutions.
Its probiotics arm – CKD Bio – is currently selling four probiotic products under the brand Youguth.
Coming in powdered sachets, the probiotics are said to provide benefits for gut, bone and skin health, as well as boosting the body’s immunity.
WOAH! Protein-packed ice cream and drinks shaking up the Singapore market
WOAH! Protein is achieving success in the Singapore market with its novel protein ice cream containing L-leucine, which was originally created for the founder’s mother who was undergoing treatment for leukaemia.
According to its founder, Edward Foo, one serving of ice cream (100g) provides 11.7g of protein and 4g of L-leucine. Mainstream ice cream contain around 5g of protein per serving.
The high protein ice cream is certified by the Health Promotion Board (HPB) in Singapore as a healthier choice product, and is also lower in calories, carbohydrate and sugar.
BTS power: South Korean supplement firm taps on boyband appeal to gain young consumers
South Korean dietary supplement firm Nutrione is leveraging on the popularity of K-pop boyband BTS to attract young consumers.
The firm has recently sealed a one-year exclusive licensing deal of BT21 for use on the packaging of its supplement products in April this year.
BT21 is a series of cartoon characters co-created by instant messaging app LINE FRIENDS and South Korean boyband BTS.
Amway China partners with government-led R&D project to internationalise TCM
Amway China has entered into a partnership with a government led R&D initiative to promote the use of TCM worldwide.
The partnership will see the firm take part in the country’s 13th five-year-plan R&D plan, in order to standardise, modernise, and internationalise the use of TCM.
The 13th five-year-plan runs from 2016 to 2020, and stipulates the objectives and plans for economic and social development in China.
Bayer opens first R&D center in China to tap on growing personalised and sports nutrition trends
Bayer Consumer Health has opened its first APAC R&D Center in Qidong, Jiangsu Province in China to cater its products and solutions for Chinese consumers.
The company said the increasing awareness of self-care, rising living standards, ageing population, and healthier lifestyles of Chinese consumers had created a large opportunity for China’s health food market.
According to a PWC report, China’s health food market will increase by RMB 100 billion (US$14bn) by 2022. Research data from Hong Kong Trade Development Council showed total sales of health food in China amounted to RMB290 billion in 2018.